SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NeuroInvestment who wrote (975)1/25/2000 6:56:00 PM
From: Rick Strange   of 1386
 
Thanks for the feedback. One wonders sometimes if the FDA is the gateway or the roadblock to quality healthcare when it comes to our drug and medical device supply. Logic too often seems to be bogged down by their dogged "non passerent" (THEY SHALL NOT PASS) attitude. Sometimes it is necessary to take limited but yet controllable risk to achieve an objective, especially when there are no alternatives.

I think they have milked the Thalidamide story (how many decades old) for about as far as it will go and should start taking a proactive course toward reducing the inane cost and time to bring new lifesaving medical developments to market.

Maybe it is time that Congress started conducting oversight hearings to find out why the FDA has ignored, or at best, paid only lip service to some FDA reform legislation passed years ago. I'll step down off of my soap box now.

Thanks again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News